Results 271 to 280 of about 861,248 (298)
Some of the next articles are maybe not open access.

Single domain antibodies

2006
Classical antibodies are complex assemblies, difficult to produce in bacteria, and too bulky for many medical or research applications. Therefore, substantial efforts aimed at finding simpler miniaturised antibodies. Heavy-chain antibodies in camelids are a natural source of such mini-antibodies. Moreover, their antigen-binding domain (named Nanobody),
openaire   +1 more source

From Whole Monoclonal Antibodies to Single Domain Antibodies: Think Small

2012
The development of therapeutic monoclonal antibodies over the last 35 years has led to the emergence of a new class of useful therapeutic molecules. These "first generation" antibodies have been obtained thanks to the conjugated and huge efforts of both academic and biotech researchers.
openaire   +2 more sources

Applications of single-cell RNA sequencing in drug discovery and development

Nature Reviews Drug Discovery, 2023
Joon Sang Lee   +2 more
exaly  

Integrated analysis of multimodal single-cell data

Cell, 2021
Yuhan Hao   +2 more
exaly  

SINGLE DOMAIN ANTIBODIES

The Lancet, 1989
openaire   +1 more source

The technological landscape and applications of single-cell multi-omics

Nature Reviews Molecular Cell Biology, 2023
Zhiliang Bai, Rahul Satija, Rong Fan
exaly  

Single Domain Antibodies - Methods and Protocols

2012
The development of the hybridoma technology created the possibility to obtain unlimited amounts of monoclonal antibodies (mAb) with high specificity and affinity for any target and to introduce mAbs in a wide range of applications; however, the bulky size of mAbs, costly production, and cumbersome engineering hampered regularly their streamlined ...
openaire   +1 more source

Home - About - Disclaimer - Privacy